In Vitro Antibacterial Activity of the Ceftazidime-Avibactam (NXL104) Combination against Pseudomonas aeruginosa Clinical Isolates

The β-lactamase inhibitor avibactam (NXL104) displays potent inhibition of both class A and C enzymes. The in vitro antibacterial activity of the combination ceftazidime-avibactam was evaluated against a clinical panel of Pseudomonas aeruginosa isolates. Avibactam offered efficient protection from h...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Levasseur, Premavathy, Girard, Anne-Marie, Claudon, Monique, Goossens, Herman, Black, Michael T., Coleman, Kenneth, Miossec, Christine
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2012
Assuntos:
Susceptibility
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3294935/
https://ncbi.nlm.nih.gov/pubmed/22214778
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.06064-11
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados